Marc Dunoyer, the companys rare disease head, in a statement called Ultomiris a transformative treatment option for NMOSD, with the potential to eliminate relapses with a convenient dosing schedule every eight weeks. The approval was backed by data from a Phase III trial that met its primary efficacy endpoint, preventing relapse in all 58 treated patients over a median of 73.5 weeks, compared to 20 relapses in the placebo arm of a trial for AstraZenecas other NMOSD therapy Soliris
Can you switch from daily oral to weekly injectable GLP-1
Adjust Your Eating Habits Small changes in how and what you eat can make a big difference: Eat smaller, more frequent meals throughout the day (every 3-4 hours) Start with a small breakfast, even if you feel nauseousnot eating can actually make nausea worse Eat slowly and stop when you feel full Avoid high-fat and high-fiber foods during the first few days after starting or increasing your dose Limit alcohol and carbonated beverages Stay well-hydrated throughout the day Natural Remedies Some people find relief with: Ginger or peppermint tea Acupressure bands Eating bland, easy-to-digest foods when nausea strikes When to Consider Medication If dietary changes arent enough, talk to your healthcare provider about anti-nausea medications
Those comments were made by participants in two trialsSURPASS-2 and SURPASS-3that gave a new drug called tirzepatide (sold by Eli Lilly as Mounjaro) to people with type 2 diabetes
Esto es as porque ha demostrado ser un tratamiento eficaz tanto en la reduccin de la hemoglobina glicosilada (HbA1c) as como del peso con bajo riesgo de hipoglucemias (las principales dificultades a las que se enfrentan las personas con diabetes tipo 2)
Tirzepatide alone achieves 20.9% weight loss in SURMOUNT-1, which approaches or matches what phentermine-plus-semaglutide combinations achieve in observational data
